Optical Brightening Agent CXT

We are Optical Brightening Agent CXT CAS:16090-02-1-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Optical Brightening Agent CXT
 
Main composition
C.I.No:71
CAS No:16090-02-1
EINECS:240-245-2
Molecular Mass:924.91
Formula:C40H38N12O8S2Na2
 
Technical index  
Appearance:White or yellowish powder
Ionic Character:Anionic
Whiteness:±1.5 comparing with standard sample
Moisture Content:≤5.0%
Odour:Ammoniacal odour free or a little ammoniacal odour
 
Performance and Features  
1.CXT is suitable for soap and washing powder, can increase the whiteness of the detergent;
2.Adding CXT to detergent powder before spray drying. CXT can homogenize with detergent powder through spray drying;
3.Using the detergent containing CXT can make the cloths cleaner and brighter.
The recommended dosage is 0.04~0.2% (% W/W Detergent).
 
Packaging and Storage:
Packaging with 25kg bag, 25kg carton, 500kg bag or according to customer's request.
Shelf-life: 2 years, store under the room temperature, avoid sunlight and moisture.

Optical Brightening Agent CXT


Related News: AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.Triethoxy(3-glycidyloxypropyl)silane CAS:2602-34-8 AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.556-81-0 AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.630423-36-8 “This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.”This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment,” Mankind Pharma Director of Marketing Sanjay Koul said in a statement.

Related Products
Product Name
(3R,4S)-tert-Butyl 2-oxo-4-phenyl-3-(triethylsilyloxy)azetidine-1-carboxylate Cas:149198-47-0 View Details
Propionyl chloride View Details
2-甲基-3-甲硫基呋喃 View Details
HEMATOPORPHYRIN HYDROCHLORIDE Cas:17471-45-3 manufacturer TBNPA Cas:36483-57-5 manufacturer calcifediol monohydrate Cas:63283-36-3 manufacturer 1-Fluoro-4-(1-methylethenyl)benzene Cas:350-40-3 manufacturer MICROCRYSTALLINE CELLULOSE Cas:9004-34-6 manufacturer